PF-Atlas › Clinical Trials › NCT01199887
Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis
IW001 · Phase 1
Registry ID
NCT01199887
Phase
Phase 1
Status
Completed
Drug / intervention
IW001
Sponsor
ImmuneWorks
Start
2010-09
About this trial
IW001 is evaluated in NCT01199887, a Phase 1 idiopathic pulmonary fibrosis study sponsored by ImmuneWorks. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01199887 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.